These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10470421)

  • 21. Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position.
    Helvie MA; Bevers TB
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1398-1404. PubMed ID: 30442738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size calculations in studies of test accuracy.
    Obuchowski NA
    Stat Methods Med Res; 1998 Dec; 7(4):371-92. PubMed ID: 9871953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic tests 4: likelihood ratios.
    Deeks JJ; Altman DG
    BMJ; 2004 Jul; 329(7458):168-9. PubMed ID: 15258077
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for disease: making evidence-based choices.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):73-6. PubMed ID: 16482730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncertainty-based medicine.
    Rosenfeld RM
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):5-7. PubMed ID: 12574751
    [No Abstract]   [Full Text] [Related]  

  • 26. Tele-practice guidelines for the symptom management of children undergoing cancer treatment.
    Tsimicalis A; De Courcy MJ; Di Monte B; Armstrong C; Bambury P; Constantin J; Dagelman B; Eves M; Jansen P; Honeyford L; Stregger D;
    Pediatr Blood Cancer; 2011 Oct; 57(4):541-8. PubMed ID: 21319280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical use of diagnostic tests (Part 1): Analysis of the properties of a diagnostic test].
    Cerda L J; Cifuentes A L
    Rev Chilena Infectol; 2010 Jun; 27(3):205-8. PubMed ID: 20737121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critique on contemporary reporting of likelihood ratios in test power analysis.
    Weissler AM; Bailey KR
    Mayo Clin Proc; 2004 Oct; 79(10):1317-8. PubMed ID: 15473417
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence-based laboratory medicine: addressing bias, generalisability and applicability in studies on diagnostic accuracy. The STARD initiative.
    McQueen M
    Clin Chem Lab Med; 2003 Jan; 41(1):1. PubMed ID: 12636041
    [No Abstract]   [Full Text] [Related]  

  • 30. Standardisation and outcomes audit: a step forward in surgical oncology.
    González-Moreno S
    Clin Transl Oncol; 2010 Jun; 12(6):389-90. PubMed ID: 20534391
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?
    Oseso LN; Chiao EY; Bender Ignacio RA
    J Natl Compr Canc Netw; 2018 Aug; 16(8):927-932. PubMed ID: 30099368
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of the clinical utility of diagnostic versus therapeutic interventions in oncology: related but quite different processes.
    Markman M
    Curr Oncol Rep; 2006 Nov; 8(6):407-8. PubMed ID: 17040617
    [No Abstract]   [Full Text] [Related]  

  • 33. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
    McDougall IR
    Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparing dichotomous screening tests when individuals negative on both tests are not verified.
    Chock C; Irwig L; Berry G; Glasziou P
    J Clin Epidemiol; 1997 Nov; 50(11):1211-7. PubMed ID: 9393377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chapter 2: medical tests guidance (2) developing the topic and structuring systematic reviews of medical tests: utility of PICOTS, analytic frameworks, decision trees, and other frameworks.
    Samson D; Schoelles KM
    J Gen Intern Med; 2012 Jun; 27 Suppl 1(Suppl 1):S11-9. PubMed ID: 22648670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of nonrandomized trials in the evaluation of oncology drugs.
    Simon R; Blumenthal GM; Rothenberg ML; Sommer J; Roberts SA; Armstrong DK; LaVange LM; Pazdur R
    Clin Pharmacol Ther; 2015 May; 97(5):502-7. PubMed ID: 25676488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Danish clinical guidelines (Klaringsrapporter, 1996-2001: Insufficient evidence presented for the diagnostic accuracy of recommended clinical-biochemical tests].
    Jørgensen PE; Madsen JS; Jørgensen LG; Larsen TB; Hilden J; Magid E
    Ugeskr Laeger; 2004 Apr; 166(18):1667-70. PubMed ID: 15174403
    [No Abstract]   [Full Text] [Related]  

  • 38. Critically appraising studies reporting assessing diagnostic tests.
    O'Connor A; Evans RB
    Vet Clin North Am Small Anim Pract; 2007 May; 37(3):487-97. PubMed ID: 17466752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Area under the ROC curve for a binary diagnostic test.
    Desbiens NA
    Med Decis Making; 2001; 21(5):421-2. PubMed ID: 11575492
    [No Abstract]   [Full Text] [Related]  

  • 40. Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der Praxis.
    Bokemeyer C; Busse R; Engel J; Gebauer A; Hallek M; Heinemann V; Lüftner D; Wörmann B
    Oncol Res Treat; 2018; 41 Suppl 3():2-26. PubMed ID: 30056452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.